American Diabetes Association Recognizes Use of Autonomous AI for Diabetes Care

In its new set of clinical standards, the American Diabetes Association (ADA) recognizes the use of autonomous artificial intelligence (AI) for the screening of some medical conditions. Experts believe the move could help some skeptics change their minds when it comes to using AI in clinical care.

Related John Hancock Collaborating with Verily and Onduo for Virtual Diabetes Management

The ADA’s 2020 Standards of Medical Care in Diabetes states that, “AI systems that detect more than mild diabetic retinopathy and diabetic macular edema authorized for use by the FDA represent an alternative to traditional screening approaches.”

To date, IDx-DR is the first and only FDA-authorized autonomous AI diagnostic system for the detection of diabetic retinopathy and macular edema. It is currently in use at a number of large health systems that each serve tens of thousands of people with diabetes and have struggled to implement diabetic retinopathy eye exams at scale for their large diabetes population, says a press release.

“The ADA’s inclusion of our technology in its Standards of Care marks a significant move toward mainstream adoption of autonomous AI in clinical care,” said Michael Abramoff, MD, PhD, Founder and Executive Chairman at IDx. “Our early customers are visionary leaders who foresaw that autonomous AI would one day become a standard of care for diabetic retinopathy screening, and taking that leap is paying off for them. Already, health systems that are using IDx-DR have experienced significant improvements in accessibility, efficiency and compliance rates, unleashing massive potential for cost savings and improved patient outcomes.”

Image: Pixabay

The Standards of Care were published last week in Diabetes Care, the highest-ranked, peer-reviewed journal in the field of diabetes treatment and prevention. Physicians, healthcare systems, health insurers and quality of care organizations look to the ADA’s Standards of Care for consensus and evidence-based best practices to improve health outcomes for people with diabetes.

Related Stanford’s Artificial Intelligence Institute Aims to Put Humans at the Center of this Field

The ADA’s Standards of Care, is intended to provide clinicians, patients, researchers, payers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. The Standards of Care recommendations are not intended to preclude clinical judgment and must be applied in the context of excellent clinical care, with adjustments for individual preferences, comorbidities, and other patient factors, ADA says.

from Wearable Technologies https://ift.tt/2MTmHoP

Insulet Launches its Omnipod DASH Insulin Management System in Europe

Insulet, a maker of wearable Insulin Management System, based in Massachusetts, announced the launch of its Omnipod DASH™ Insulin Management System in the United Kingdom and the Netherlands. People with diabetes at King’s College Hospital in London and a leading hospital in Amsterdam are now among the first in Europe to access Insulet’s new system.

Designed to be used by individuals of all ages, the tubeless Omnipod DASH System is simple and easy to use. It provides up to three days of non-stop insulin delivery, without the need for daily injections and allows users to discreetly manage their diabetes via a new touchscreen interface, reports Business Wire.

“King’s is proud to be one of the first centers to offer the Omnipod DASH System in Europe, which will help expand choice available for people with diabetes, including those on Multiple Daily Injections who are using or considering the use of insulin pump therapy,” said Dr Pratik Choudhary, Senior Lecturer and Consultant in Diabetes at King’s College London. “The system is so intuitive and easy to use that it allows us as Healthcare Professionals to focus more of our time with our patients rather than the technology.”

Image: Omnipod

The Omnipod DASH System received FDA clearance in June 2018, and CE marking in September 2019.

Insulet recently won ‘Medical Device Company of the Year’ at the prestigious Diabetes Professional Conference in October 2019, London in recognition for excellence in launching direct operations in Europe since July 1st 2018.

“We are highly focused on individualized care and freedom of choice, both of which are exceptionally important when it comes to the overall customer experience,” said DJ Cass, General Manager, Europe, Insulet Corporation. “Our customers were at the heart of our development efforts when designing our new product innovation and we are proud to build on the existing advantages of Pod therapy, which provides flexibility, ease of use and discretion.”

Read more FDA Authorizes Tandem’s Interoperable, Automated Insulin Dosing Controller

The Omnipod DASH System consists of two components: a tubeless, waterproof, Bluetooth enabled Pod that holds up to 200 units of insulin and a modern, color touch-screen Personal Diabetes Manager (PDM) that controls the Pod.

from Wearable Technologies https://ift.tt/36liqlR

Best smartwatch deals for January 2020: Samsung, Fitbit, and Apple Watch sales

Smartwatches make life easier by sending alerts right on your wrist. Many also provide fitness-tracking features, so now is a great time to pick one up for cheap. With so many models available, you can find a deal on one almost all of the time.

from Digital Trends https://ift.tt/2iptL0f

Neurable Raises $6 Million to Build Intuitive, User-Friendly Neurotechnology Products

Boston-based neurotechnology company Neurable has raised $6 million in Series A funding led by M Ventures. Other participants were Innospark Ventures and existing investors such as Loup Ventures and Point Judith Capital. The new fund will allow Neurable to evolve past virtual reality (VR) applications and create “everyday” brain-computer interfaces: accessible, intuitive, and user-friendly products that will bring the benefits of neurotechnology to the masses.

The company’s next product will be a pair of consumer headphones that measure cognitive state and provide hands-free control for mobile devices.

Neurable first made news with its breakthrough technology that allows the user to control virtual reality (VR) with their mind. Since then, it co-developed a VR game with Red Bull that debuted at Red Bull’s Lollapalooza outpost in August 2019, created new EEG interpretation tools, and is now deploying its software tools in VR simulation training applications.

Neurable CEO Dr. Ramses Alcaide said his company’s transition from VR to broader applications is a natural one. “We are applying many of the same industry-leading machine learning techniques from our VR-based applications to our headphone prototypes,” he said. “By making a brain-computer interface in the form of headphones, we will be able to provide the benefits of Neurable’s technology to many more people.”

Neurable’s next product will be a pair of consumer headphones that measure cognitive state and provide hands-free control for mobile devices. (Image: Pexels)

Read more NeoRhythm – Neurostimulation Headband that Hacks Your Brain to Remove Stress and Fatigue

Jamie Alders is Neurable’s Vice President of Product. He joined the company in 2018 and has twelve years of experience in engineering and product management at Bose. He said that a pair of headphones is an ideal brain-sensing wearable because millions of people already wear it on their heads every day. “Compared to other potential head-worn electronics form factors, headphones benefit from mature sales channels, seasoned supply chain, and proven customer value,” Alders said.

Neurable’s mission is to make technology universally accessible, intuitive, and empowering through advanced applications of neurotechnology, the company said. Dr. Alcaide describes the company’s vision: “Brain-computer interfaces will enable a world where you will communicate beyond the limits of today’s computer interfaces. For example, users will be able to send a text by thinking — instead of typing — and those texts will carry an emotional texture beyond the words of the message alone.”

from Wearable Technologies https://ift.tt/2QFrivV

Arrow Electronics Collaborates with Geniatech and ON Semiconductor for Workplace Safety Wearable

American electronic components and computer products company Arrow Electronics has collaborated with ON Semiconductor and original design manufacturer Geniatech to develop a wearable device that enables real-time monitoring of working environments for improved safety.

Read more SolusGuard Launches Wearable Alarm to Protect Lone Workers

The Multi-Sensor-Online wearable device MuSeOn 1.1 is based on ON Semiconductor’s RSL10 Sensor Development Kit. The platform features RSL10, the industry’s lowest power Bluetooth 5 radio SoC, and comprises five industrial-grade sensors that can measure, detect and identify varying environmental conditions. It is integrated with local wireless and cloud services that enable companies to monitor working environments in real-time to maintain and improve safety levels for employees, reports Business Wire.

The RSL10 is extremely energy efficient. It incorporates an on-board processing core, several peripherals, integrated power management and large internal memory.

“Arrow, ON Semiconductor and Geniatech have joined forces to realize the first industrial-grade low-power multi-sensor platform, which enables a wide range of commercial applications, such as worker safety,” said JinJun Fang, CEO of Geniatech. “The solution helps companies and employees monitor worker safety in real-time driving compliance with safety policies, and helps protect workers and assets from risks.”

Image: Wikimedia Commons (Public domain)

MuSeOn 1.1 features sensors for air quality, humidity, pressure and temperature, allowing for recognition of the wearer’s activity, together with indoor navigation and positioning. There is an ambient light sensor with wide operating range and an omnidirectional, stereo digital microphone. MuSeOn 1.1 has a dual RFID interface and is housed in an IP65-rated case.

“MuSeOn 1.1 provides an end-to-end solution that delivers real-time insights into workplace conditions,” said Aiden Mitchell, global vice president of IoT at Arrow. “The combination of data gathered and cloud analytics provided through the Arrow IoT ecosystem will help to improve workplace safety, drive compliance with safety policies and help protect workers from risks.”

Read more Wearables with IoT Connected Sensors Helping to Improve Worker Safety

Wiren Perera, who heads IoT at ON Semiconductor, said, “With a range of environmental sensors alongside the industry-leading RSL10 radio, we knew the possibilities for the RSL10 Sensor Kit were nearly endless. We are very excited to see how this platform has been taken one step closer to users with the MuSeOn 1.1 solution.”

MuSeOn 1.1 is manufactured and designed by Geniatech, and is exclusively available from Arrow.

from Wearable Technologies https://ift.tt/39wbDaN

CES 2020: What to expect from the annual tech bonanza

Christmas is over, the new year has begun, and that can only mean one thing: There's just about a week to go before the world's leading manufacturers take to Las Vegas to showcase their latest hardware at CES 2020. Here's everything you need to know.

from Digital Trends https://ift.tt/2RzbGft

Best Tech Deals To Start 2020: AirPods, Instant Pot, PS4 Pro, and more

We made it, folks. It's 2020. Nothing exploded. The world is still intact. Don't believe us? Just scroll down -- there's no shortage of fantastic deals, the first thing that comes to mind when we think of the norm, to choose from.

from Digital Trends https://ift.tt/2QfwqrG